GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Solasia Pharma KK (STU:9SO) » Definitions » Gross Margin %

Solasia Pharma KK (STU:9SO) Gross Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Solasia Pharma KK Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Solasia Pharma KK's Gross Profit for the three months ended in Dec. 2024 was €0.00 Mil. Solasia Pharma KK's Revenue for the three months ended in Dec. 2024 was €0.00 Mil. Therefore, Solasia Pharma KK's Gross Margin % for the quarter that ended in Dec. 2024 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.

Warning Sign:

Solasia Pharma KK gross margin has been in long-term decline. The average rate of decline per year is -6.8%.


The historical rank and industry rank for Solasia Pharma KK's Gross Margin % or its related term are showing as below:

STU:9SO' s Gross Margin % Range Over the Past 10 Years
Min: 30.82   Med: 58.54   Max: 94.96
Current: 30.82


During the past 12 years, the highest Gross Margin % of Solasia Pharma KK was 94.96%. The lowest was 30.82%. And the median was 58.54%.

STU:9SO's Gross Margin % is ranked worse than
78.95% of 955 companies
in the Drug Manufacturers industry
Industry Median: 47.59 vs STU:9SO: 30.82

Solasia Pharma KK had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Solasia Pharma KK was -6.80% per year.


Solasia Pharma KK Gross Margin % Historical Data

The historical data trend for Solasia Pharma KK's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Solasia Pharma KK Gross Margin % Chart

Solasia Pharma KK Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.74 66.73 60.62 54.61 58.56

Solasia Pharma KK Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56.16 39.58 - 3.40 -

Competitive Comparison of Solasia Pharma KK's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Solasia Pharma KK's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Solasia Pharma KK's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Solasia Pharma KK's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Solasia Pharma KK's Gross Margin % falls into.


;
;

Solasia Pharma KK Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Solasia Pharma KK's Gross Margin for the fiscal year that ended in Dec. 2024 is calculated as

Gross Margin % (A: Dec. 2024 )=Gross Profit (A: Dec. 2024 ) / Revenue (A: Dec. 2024 )
=1.1 / 1.962
=(Revenue - Cost of Goods Sold) / Revenue
=(1.962 - 0.813) / 1.962
=58.56 %

Solasia Pharma KK's Gross Margin for the quarter that ended in Dec. 2024 is calculated as


Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Solasia Pharma KK  (STU:9SO) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Solasia Pharma KK had a gross margin of N/A% for the quarter that ended in Dec. 2024 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Solasia Pharma KK Gross Margin % Related Terms

Thank you for viewing the detailed overview of Solasia Pharma KK's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Solasia Pharma KK Business Description

Traded in Other Exchanges
Address
2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.

Solasia Pharma KK Headlines

No Headlines